|Bid||0.19 x 9834400|
|Ask||0.20 x 752800|
|Day's Range||0.19 - 0.20|
|52 Week Range||0.09 - 0.28|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Alkermes and Biogen have inked a pact to develop and commercialize ALKS 8700, which is in Phase 3 development for treating relapsing forms of multiple sclerosis.
SYDNEY/MELBOURNE, Oct 31 (Reuters) - Battery makers are increasingly turning to nickel to help power growing global electric car sales, but only half of the world's producers of the metal are likely to benefit, mining analysts and executives say. Lithium batteries containing nickel, which helps keep a charge over longer distances, are being installed in electric cars from Tesla's top-of-the-line Model X to General Motors Co modestly-priced Chevy Bolt. The battery boom promises a new and growing market for miners producing high-grade nickel products.
Paratek, Cyclacel and Benitec stocks led a biotech surge on Tuesday, rising on strong trial results.
Benitec Biopharma saw its shares more than double on Tuesday after the company gave a business update on its ddRNAi technology for the development of therapeutics for the treatment of ocular diseases.
Benitec (BNTC) announced that its proposed candidate, BB-301, received Orphan Drug Designation in the EU for the treatment of ocularpharyngeal muscular dystrophy.
A few biotech and pharma companies were on the move Tuesday. A few of the smaller caps made tremendous gains on the day, as the fourth-quarter earnings season is kicking off.